MedPath

Method validation (pilot study) on the effectiveness of PINK! Coaching app for digital therapy and follow-up care for patients with breast cancer - a prospective, randomized-controlled feasibility study

Phase 4
Conditions
C50
Malignant neoplasm of breast
Registration Number
DRKS00025811
Lead Sponsor
Brustzentrum LMU München
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Confirmed diagnosis of a malignant tumor of the breast,> 18 years old, smartphone possession, German-speaking, (1) during acute therapy or (2) in follow-up care

Exclusion Criteria

severe psychological stress (PHQ-9 total score at baseline> 20), severe cognitive impairment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the PHQ-9 total score after 12 weeks
Secondary Outcome Measures
NameTimeMethod
EORTC-QLQ-C30<br>PAM-13<br>EHEALS<br>IPAQ SF<br>BMI<br><br>(all after 12 weeks with 4 measuring points each - baseline, T1 after 4 weeks, T2 after 8 weeks, T3 after 12 weeks)
© Copyright 2025. All Rights Reserved by MedPath